Keywords: correction, novartis/schwarz, deal, erroneously, stated, marketletter, july

CORRECTION: Novartis/Schwarz deal

Article | 07 August 2001

It was erroneously stated in Marketletter July 30 that Schwarz Pharma'sSpanish subsidiary, CEPA Schwarz Pharma, is to market a generic version ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Schwarz Pharma

Novartis

Go to company listing

Related Drugs

Diovan

Valsartan

Go to drug listing